Krystal Biotech Inc (KRYS)

Stock-Based Compensation

$14.16M

Quarterly · Period ending: · USD

KRYS logo

KRYS Stock-Based Compensation

Latest reported$14.16M
KRYS Quarterly Stock-Based Comp ($4.00K → $14.16M)
High-resolution chart · PNG

KRYS stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
14,156,000
13,609,000
13,764,000
0
14,119,000
13,478,000
13,356,000
13,316,000
13,156,000
9,299,000
9,853,000
8,312,000
11,331,000
10,437,000
9,552,000
9,059,000
8,189,000
6,430,000
5,145,000
3,666,000
4,195,000
2,313,000
570,000
1,356,000
807,000
539,000
323,000
278,000
325,000
313,000
302,000
278,000
147,000
65,000
58,000
53,000
44,000
91,000
26,000
4,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.